158 related articles for article (PubMed ID: 37800295)
1. [Two Cases of Catheter-Related Venous Thrombosis Treated with Direct Oral Anticoagulants(DOAC)].
Terasawa T; Fukuda K; Yanai A; Matsuo C
Gan To Kagaku Ryoho; 2023 Sep; 50(9):993-996. PubMed ID: 37800295
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2).
Davies GA; Lazo-Langner A; Gandara E; Rodger M; Tagalakis V; Louzada M; Corpuz R; Kovacs MJ
Thromb Res; 2018 Feb; 162():88-92. PubMed ID: 28416213
[TBL] [Abstract][Full Text] [Related]
3. Venous Thrombosis Recurrence After Catheter-Related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Retrospective Analysis.
Hakem R; Soudet S; Diouf M; Sevestre MA
Angiology; 2024 Aug; 75(7):658-665. PubMed ID: 37195809
[TBL] [Abstract][Full Text] [Related]
4. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm.
Goltz JP; Schmid JS; Ritter CO; Knödler P; Petritsch B; Kirchner J; Hahn D; Kickuth R
J Vasc Access; 2012; 13(1):79-85. PubMed ID: 21786241
[TBL] [Abstract][Full Text] [Related]
5. Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis.
Wang TF; Kou R; Carrier M; Delluc A
J Thromb Haemost; 2024 Mar; 22(3):749-764. PubMed ID: 38065528
[TBL] [Abstract][Full Text] [Related]
6. Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
Vedovati MC; Tratar G; Mavri A; Mazzetti M; Salazar Rosa V; Pierpaoli L; Cotugno M; Agnelli G; Becattini C
Int J Cardiol; 2021 Sep; 339():158-163. PubMed ID: 34245794
[TBL] [Abstract][Full Text] [Related]
7. Central venous catheter-related thrombosis in children and adults.
Citla Sridhar D; Abou-Ismail MY; Ahuja SP
Thromb Res; 2020 Mar; 187():103-112. PubMed ID: 31981840
[TBL] [Abstract][Full Text] [Related]
8. Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis.
Bleker SM; van Es N; Kleinjan A; Büller HR; Kamphuisen PW; Aggarwal A; Beyer-Westendorf J; Camporese G; Cosmi B; Gary T; Ghirarduzzi A; Kaasjager K; Lerede T; Marschang P; Meijer K; Otten HM; Porreca E; Righini M; Verhamme P; van Wissen S; Di Nisio M
J Thromb Haemost; 2016 May; 14(5):973-81. PubMed ID: 26866515
[TBL] [Abstract][Full Text] [Related]
9. Risk for recurrence of symptomatic upper-extremity deep vein thrombosis in patients without cancer: Analysis of three RIETE cohorts.
Núñez Fernández MJ; Padín Paz EM; Vázquez Temprano N; Nieto Rodríguez JA; Marchena Yglesias PJ; Imbalzano E; Montenegro AC; Fernández Jiménez B; Rivera A; Espitia O; Monreal M
Vasc Med; 2023 Aug; 28(4):324-330. PubMed ID: 37272085
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
11. Upper-Extremity Deep-Vein Thrombosis: A Retrospective Cohort Evaluation of Thrombotic Risk Factors at a University Teaching Hospital Antithrombosis Clinic.
Stone RH; Bress AP; Nutescu EA; Shapiro NL
Ann Pharmacother; 2016 Aug; 50(8):637-44. PubMed ID: 27189014
[TBL] [Abstract][Full Text] [Related]
12. Central venous catheters and upper extremity deep vein thrombosis in medical inpatients: the Medical Inpatients and Thrombosis (MITH) Study.
Winters JP; Callas PW; Cushman M; Repp AB; Zakai NA
J Thromb Haemost; 2015 Dec; 13(12):2155-60. PubMed ID: 26340226
[TBL] [Abstract][Full Text] [Related]
13. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients.
Delluc A; Le Gal G; Scarvelis D; Carrier M
Thromb Res; 2015 Feb; 135(2):298-302. PubMed ID: 25491940
[TBL] [Abstract][Full Text] [Related]
14. Upper-extremity deep vein thrombosis related to central venous port systems implanted in cancer patients.
Yukisawa S; Fujiwara Y; Yamamoto Y; Ueno T; Matsueda K; Kohno A; Suenaga M
Br J Radiol; 2010 Oct; 83(994):850-3. PubMed ID: 20223904
[TBL] [Abstract][Full Text] [Related]
15. Management of cancer-associated upper extremity deep vein thrombosis with and without venous catheters at a tertiary care center.
ALKindi SY; Chai-Adisaksopha C; Cheah M; Linkins LA
Thromb Res; 2018 Jun; 166():92-95. PubMed ID: 29704767
[TBL] [Abstract][Full Text] [Related]
16. Duration of anticoagulation for upper extremity deep vein thrombosis associated with cancer and central venous catheter: Outcome of a cohort study.
Turrian U; Lapebie FX; Bura-Rivière A
J Med Vasc; 2022 Feb; 47(1):11-18. PubMed ID: 35393086
[TBL] [Abstract][Full Text] [Related]
17. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature.
Schastlivtsev I; Lobastov K; Tsaplin S; Kanzafarova I; Barinov V; Laberko L; Rodoman G; Zhuravlev S
Thromb Res; 2019 Sep; 181():24-28. PubMed ID: 31326717
[TBL] [Abstract][Full Text] [Related]
19. [Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D; Fan SM; Li SY; Zhang JT; Wang HM; Zhao XH; Zheng LJ; Liang P; Xi GB; Zhao LM; Zhang YR; Yuan P
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):256-262. PubMed ID: 38494772
[No Abstract] [Full Text] [Related]
20. Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review.
Bleker SM; van Es N; van Gils L; Daams JG; Kleinjan A; Büller HR; Di Nisio M
Thromb Res; 2016 Apr; 140 Suppl 1():S81-8. PubMed ID: 27067985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
